Literature DB >> 6296229

Hotting-up the complement-fixation test.

C J Ronalds, A E Hardiman, P D Griffiths.   

Abstract

A detailed investigation into the effect of modifying the incubation temperature of the complement-fixation (CF) test is described. For varicella-zoster virus cytomegalovirus and rubella virus, increasing the incubation temperature progressively increased the sensitivity of the CF test to reach a maximum at 15 degrees C, at which temperature the geometric mean titre of seropositive samples was significantly greater than that found at 4 degrees C. For these three viruses, each serum shown to contain IgG antibodies by ultrasensitive radioimmunoassay procedures was detected by CF following incubation at 15 degrees C. No false-positive reactions occurred at 15 degrees C, but it was our impression that anticomplementary activity was enhanced at this temperature. Significant increases in antibody titre at 15 degrees C were also seen when measles virus, respiratory syncytial virus, adenovirus and Mycoplasma pneumoniae were employed as CF antigens. The results demonstrate that the CF test should be performed at 15 degrees C if optimum sensitivity is to be achieved. The ability of the test to detect significant rises in antibody titre was not impaired at the higher incubation temperature.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6296229      PMCID: PMC2134194          DOI: 10.1017/s0022172400063920

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  9 in total

1.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

2.  Technique of complementfixation test applicable to the diagnosis of virus diseases.

Authors:  C M BRADSTREET; C E TAYLOR
Journal:  Mon Bull Minist Health Public Health Lab Serv       Date:  1962-05

3.  A comparison of complement fixation, indirect immunofluorescence for viral late antigens, and anti-complement immunofluorescence tests for the detection of cytomegalovirus specific serum antibodies.

Authors:  P D Griffiths; K J Buie; R B Heath
Journal:  J Clin Pathol       Date:  1978-09       Impact factor: 3.411

4.  Comparative evaluation of several complement fixation techniques for laboratory diagnosis of the rickettsioses.

Authors:  J H SCHUBERT; S M STANFORD; E J TIFFANY
Journal:  J Lab Clin Med       Date:  1951-03

5.  A comparison of three tests for rubella antibody screening.

Authors:  P Morgan-Capner; H J Pullen; J R Pattison; D E Bidwell; A Bartlett; A Voller
Journal:  J Clin Pathol       Date:  1979-06       Impact factor: 3.411

6.  The development and evaluation of a solid-phase radioimmunoassay (RIA) procedure for the determination of susceptibility to varicella.

Authors:  A Campbell-Benzie; H O Kangro; R B Heath
Journal:  J Virol Methods       Date:  1981-02       Impact factor: 2.014

7.  Evaluation of a radioimmunoassay for IgM-class antibodies against cytomegalovirus.

Authors:  H O Kangro
Journal:  Br J Exp Pathol       Date:  1980-10

8.  Experiences with solid-phase "radioimmunoassay" in the rapid diagnosis of hepatitis B.

Authors:  C H Cameron
Journal:  J Med Virol       Date:  1978       Impact factor: 2.327

9.  A prospective study of primary cytomegalovirus infection in pregnant women.

Authors:  P D Griffiths; A Campbell-Benzie; R B Heath
Journal:  Br J Obstet Gynaecol       Date:  1980-04
  9 in total
  3 in total

1.  Screening tests for antibodies to cytomegalovirus: an evaluation of five commercial products.

Authors:  P C Grint; C J Ronalds; H O Kangro; A Campbell-Benzie; F Ward; A E Hardiman; R B Heath
Journal:  J Clin Pathol       Date:  1985-09       Impact factor: 3.411

2.  Efficacy of varicella vaccine in patients with solid tumours.

Authors:  R B Heath; J S Malpas; H O Kangro; A Ward; J M McEniery; J E Kingston
Journal:  Arch Dis Child       Date:  1987-06       Impact factor: 3.791

3.  An in-depth study of Crohn's disease in two French families.

Authors:  H J Van Kruiningen; J F Colombel; R W Cartun; R H Whitlock; M Koopmans; H O Kangro; J A Hoogkamp-Korstanje; M Lecomte-Houcke; M Devred; J C Paris
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.